Altered expression of the lymphocyte activation antigen CD30 in active celiac disease

References

• Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V. Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature. 1982; 299:65–67.
   PubMed Web of Science ®Google Scholar
• Stein H, Mason DY, Gerdes J, O'Conner N, Wainscoat J, Pallsen G, Gatter K, Falini B, Delsol G, Lemke H. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue. Evidence that Reed Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood. 1985; 66:848–858.
   PubMed Web of Science ®Google Scholar
• Chiarle R, Podda A, Prolla G, Gong J, Thorbecke GJ, Inghirami G. CD30 in normal and neoplastic cells. Clin Immunol. 1999; 90:157–164.
   PubMed Web of Science ®Google Scholar
• Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell. 1992; 68:421–427.
   PubMed Web of Science ®Google Scholar
• Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, McAlister IB, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Din WS, Goodwin RG, Armitage RJ. CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell. 1993; 73:1349–1360.
   PubMed Web of Science ®Google Scholar
• Smith CA, Farrah T, Goodwin RG. The TNF receptor superfamily of cellular and viral proteins: Activation, co-stimulation, and death. Cell. 1994; 76:959–962.
   PubMed Web of Science ®Google Scholar
• Tarkowski M, Chrul S, Bodalski J. The effect of IL-18 on IL-12-induced CD30 expression and IL-4 and IFN-g production by allergen and PPD specific T cells. Clin Exp Immunol. 2002; 127:78–84.
   Google Scholar
• Munk ME, Kern P, Kaufmann SH. Human CD30+ cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions. Int Immunol. 1997; 9:713–720.
   PubMed Web of Science ®Google Scholar
• Alzona M, Jack HM, Fisher RI, Ellis TM. IL-12 activates IFN-y production through the preferential activation of CD30+T cells. J Immunol. 1995; 154:9–16.
   PubMed Web of Science ®Google Scholar
• Ellis TM, Simms PE, Slivnick DJ, Jack HM, Fisher RI. CD30 is a signal-transducing molecule that defines a subset of human activated CD45RO+ T cells. J Immunol. 1993; 151:2380–2389.
   PubMed Web of Science ®Google Scholar
• Nakamura T, Lee RK, Nam SY, Al-Ramadi BK, Koni PA, Bottomly KJ. Reciprocal regulation of CD30 expression on CD4+ T cells by IL-4 and IFN-gamma. J Immunol. 1997; 158:2090–2098.
   PubMed Web of Science ®Google Scholar
• Chilosi M, Facchetti F, Notarangelo LD, Romagnani S, Del Prete G, Almerigogna F, De Carli M, Pizzolo G. CD30 cell expression and abnormal soluble CD30 serum accumulation in Omenn's syndrome: Evidence for a T helper 2-mediated condition. Eur J Immunol. 1996; 26:329–334.
   PubMed Web of Science ®Google Scholar
• Piletta PA, Wirth S, Hommel L, Saurat JH, Hauser C. Circulating skin-homing T cells in atopic dermatitis. Selective upregulation of HLA-DR, interleukin-2R, and CD30 and decrease after combined UV-A and UV-B phototherapy. Arch Dermatol. 1996; 132:1230–1232.
   Google Scholar
• Munk ME, Kern P, Kaufmann SH. Human CD30+ cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions. Int Immunol. 1997; 9:713–720.
   PubMed Web of Science ®Google Scholar
• Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: Association with autoantibodies and soluble CD30. Clin Immunol Immunopathol. 1996; 80:311–320.
   PubMedGoogle Scholar
• Schieferdecker HL, Ullrich R, Hirseland H, Zeitz M. T cell differentiation antigens on lymphocytes in the human intestinal lamina propria. J Immunol. 1992; 149:2816–2822.
   PubMed Web of Science ®Google Scholar
• Eiras P, Roldan E, Camarero C, Olivares F, Bootello A, Roy G. Flow cytometry description of a novel CD3/CD7 intraepithelial lymphocyte subset in human duodenal biopsies: Potential diagnostic value in coeliac disease. Cytometry. 1998; 34:95–102.
   PubMedGoogle Scholar
• Gerli R, Pitzalis C, Bistoni O, Falini B, Costantini V, Russano A, Lunardi C. CD30+T cells in rheumatoid synovitis: Mechanisms of recruitment and functional role. J Immunol. 2000; 164:4399–4407.
   Google Scholar
• Trier JS. Celiac sprue. N Engl J Med. 1991; 325:1709.
   PubMed Web of Science ®Google Scholar
• van Heel DA, Hunt K, Greco L, Wijmenga C. Genetics in coeliac disease. Best Pract Res Clin Gastroenterol. 2005; 19:323–339.
   PubMed Web of Science ®Google Scholar
• Sollid LM. Intraepithelial lymphocytes in celiac disease: License to kill revealed. Immunity. 2004; 21:303–304.
   Google Scholar
• Hansen HP, Kisselva T, Kobarg J, Horn-Lohrens O, Havsteen B, Lemke H. A zinc metalloproteinase is responsible for the release of CD30 on human tumor cell lines. Int J Cancer. 1995; 63:750–756.
   PubMed Web of Science ®Google Scholar
• Horie R, Watanabe T. CD30: Expression and function in health and disease. Semin Immunol. 1998; 10:457–470.
   PubMed Web of Science ®Google Scholar
• Augustin MT, Kokkonen J, Karttunen R, Karttunen TJ. Serum granzymes and CD30 are increased in children's milk protein sensitive enteropathy and celiac disease. J Allergy Clin Immunol. 2005; 115:157–162.
   PubMedGoogle Scholar
• Munk ME, Kern P, Kaufmann SH. Human CD30+ cells are induced by Mycobacterium tuberculosis and present in tuberculosis lesions. Int Immunol. 1997; 9:713–720.
   PubMed Web of Science ®Google Scholar
• Okumura M, Hidaka Y, Kuroda S, Takeoka K, Tada H, Amino N. Increased serum concentrations of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis. J Clin Endocrinol Metab. 1997; 82:1757–1760.
   PubMed Web of Science ®Google Scholar
• Krams SM, Cao S, Hayashi M, Villanueva JC, Martinez OM. Elevations in IFN-γ, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: Association with autoantibodies and soluble CD30. Clin Immunol Immunopathol. 1996; 80:311–320.
   PubMedGoogle Scholar
• Gerli R, Muscat C, Bistoni O, Falini B, Tomassini C, Agea E, Tognellini R, Biagini P, Bertotto A. High levels of the soluble form of CD30 molecule in rheumatoid arthritis (RA) are expression of CD30+ T cell involvement in the inflamed joints. Clin Exp Immunol. 1995; 102:547–550.
   PubMed Web of Science ®Google Scholar
• Sancho D, Yáñez-Mó M, Tejedor R, Sánchez-Madrid F. Activation of peripheral blood T cells by interaction and migration through endothelium: Role of lymphocyte function antigen-1/intercellular adhesion molecule-1 and interleukin-15. Blood. 1999; 93:886–896.
   PubMed Web of Science ®Google Scholar
• Ebert EC. Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology. 1998; 115:1439–1445.
   PubMedGoogle Scholar
• Ebert EC, Jabri B. Massive interleukin-12-induced interferon-γ production by interleukin-15-stimulated lamina propria lymphocytes followed by down-regulation of the interleukin-12 receptor. Immunology. 2008; 124:453–460.
   PubMed Web of Science ®Google Scholar
• León AJ, Garrote JA, Blanco-Quirós A, Calvo C, Fernández-Salazar L, Del Villar A, Barrera A, Arranz E. Interleukin 18 maintains a long-standing inflammation in coeliac disease patients. Clin Exp Immunol. 2006; 146:479–485.
   PubMed Web of Science ®Google Scholar
• Bernardo D, Garrote JA, Fernández-Salazar L, Riestra S, Arranz E. Is gliadin really safe for non-coeliac individuals? Production of interleukin 15 in biopsy culture from non-coeliac individuals challenged with gliadin peptides. Gut. 2007; 56:889–890.
   Web of Science ®Google Scholar
• Bernardo D, Garrote JA, Allegretti Y, León A, Gómez E, Bermejo-Martin JF, Calvo C, Riestra S, Fernández-Salazar L, Blanco-Quirós A, Chirdo F, Arranz E. Higher constitutive IL15R alpha expression and lower IL-15 response threshold in coeliac disease patients. Clin Exp Immunol. 2008; 154:64–73.
   PubMed Web of Science ®Google Scholar
• Maiuri L, Ciacci C, Auricchio S, Brown V, Quaratino S, Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology. 2000; 119:996–1006.
   PubMed Web of Science ®Google Scholar
• Hüe S, Mention JJ, Monteiro RC, Zhang S, Cellier C. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity. 2004; 21:367–377.
   PubMed Web of Science ®Google Scholar
• Jabri B, de Serre NP, Cellier C, Evans K, Gache C, Carvalho C, Mougenot JF, Allez M, Jian R, Desreumaux P, Colombel JF, Matuchansky C, Cugnenc H, Lopez-Botet M, Vivier E, Moretta A, Roberts AI, Ebert EC, Guy-Grand D, Brousse N, Schmitz J, Cerf-Bensussan N. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology. 2000; 118:867–879.
   PubMed Web of Science ®Google Scholar
• Meresse B, Chen Z, Ciszewski C, Tretiakova M, Bhagat G, Krausz TN, Raulet DH, Lanier LL, Groh V, Spies T, Ebert EC, Green PH, Jabri B. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity. 2004; 21:357–366.
   PubMed Web of Science ®Google Scholar
• Di Sabatino A, Ciccocioppo R, Cupelli F, Cinque B, Millimaggi D, Clarkson MM. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut. 2006; 55:469–477.
   PubMed Web of Science ®Google Scholar
• Mention JJ, Ben Ahmed M, Bègue B, Barbe U, Verkarre V, Asnafi V, Colombel JF, Cugnenc PH, Ruemmele FM, McIntyre E, Brousse N, Cellier C, Cerf-Bensussan N. Interleukin 15: A key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology. 2003; 125:730–745.
   PubMed Web of Science ®Google Scholar
• Tjon JM, Verbeek WH, Kooy-Winkelaar YM, Nguyen BH, van der Slik AR, Thompson A, Heemskerk MH, Schreurs MW, Dekking LH, Mulder CJ, van Bergen J, Koning F. Defective synthesis or association of T-cell receptor chains underlies loss of surface T-cell receptor-CD3 expression in enteropathy-associated T-cell lymphoma. Blood. 2008; 112:5103–5110.
   PubMed Web of Science ®Google Scholar
• Murray A, Cuevas D, Jones DB, Wright DH. Study of the immunohistochemistry and T cell clonality of enteropathy-associated T cell lymphoma. Amer J Pathol. 1995; 146:509–519.
   Web of Science ®Google Scholar
• Farstad IN, Johansen FE, Vlatkovic L, Jahnsen J, Scott H, Fausa O, Bjørneklett A, Brandtzaeg P, Halstensen TS. Heterogeneity of intraepithelial lymphocytes in refractory sprue: Potential implications of CD30 expression. Gut. 2002; 51:372–378.
   Google Scholar
• Gerli R, Lunardi C, Vinante F, Bistoni O, Pizzolo G, Pitzalis C. Role of CD30+T cells in rheumatoid arthritis: A counter regulatory paradigm for Th1-driven diseases. Trends Immunol. 2001; 22:72–77.
   Google Scholar
• Marsh MM. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology. 1992; 102:330–354.
   PubMed Web of Science ®Google Scholar
• Cabanne A, Vázquez H, Argonz J, Moreno ML, Nachman F, Niveloni S, Mazure R, Kogan Z, Gómez JC, Mauriño E, Bai JC. Clinical utility of counting intraepithelial lymphocytes in celiac disease intestinal mucosa. Acta Gastroenterol Latinoam. 2007; 37:20–28.
   Google Scholar
• Sugai E, Selvaggio G, Vazquez H, Viola M, Mazure R, Pizarro B, Smecuol E, Flores D, Pedreira S, Mauriño E, Gomez JC, Bai JC. Tissue transglutaminase in celiac disease: Assessment of a commercial kit. Am J Gastroenterol. 1997; 95:2318–2322.
   Google Scholar
• Olerup O, Alder A, Fogdell A. HLA-DQB1 and -DQA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) in two hours. Tissue Antigens. 1993; 41:119–134.
   PubMed Web of Science ®Google Scholar
• Corazza GR, Biagi F, Volta U, Andreani ML, De Franceschi L, Gasbarrini G. Autoimmune enteropathy and villous atrophy in adults. Lancet. 1997; 350:359–360.
   Google Scholar
• Madrigal L, Lynch S, Feighery C, Weir D, Kelleher D, O'Farrelly CJ. Flow cytometry analysis of surface major histocompatibility complex class II expression on human epithelial cells prepared from small intestinal biopsies. Immunol Meth. 1993; 158:207–214.
   Google Scholar
• Bulfone-Paus S, Dürkop H, Paus R, Krause H, Pohl T, Onu A. Differential regulation of human T lymphoblast functions by IL-2 and IL-15. Cytokine. 1997; 9:507–513.
   Google Scholar
• Kilwinski J, Berger T, Mpalaskas J, Reuter S, Flick W, Kern P. Expression of CD30 mRNA, CD30L mRNA and a variant form of CD30 mRNA in restimulated peripheral blood mononuclear cells (PBMC) of patients with helminthic infections resembling a Th2 disease. Clin Exp Immunol. 1999; 115:114–119.
   Google Scholar
• Thomas PD, Forbes A, Nicholls RJ, Ciclitira PJ. Altered expression of the lymphocyte activation markers CD30 and CD27 in patients with pouchitis. Scand J Gastroenterol. 2001; 36:258–264.
   Google Scholar
• O'Keeffe J, Mills K, Jackson J, Feighery C. T cell proliferation, MHC class II restriction and cytokine products of gliadin stimulated peripheral blood mononuclear cells (PBMC). Clin Exp Immunol. 1999; 117:269–276.
   Google Scholar
• Mizrachi A, Broide E, Buchs A, Kornberg A, Aharoni D, Bistritzer T, Rapoport MJ. Lack of correlation between disease activity and decreased stimulated secretion of IL-10 in lymphocytes from patients with celiac disease. Scand J Gastroenterol. 2002; 37:924–930.
   Web of Science ®Google Scholar
• Broide E, Scapa E, Bloch O, Shapiro M, Kimchi NA, Ben-Yehudah G, Rapoport MJ. Evidence for aberrant regulation of MAP kinase signal transduction pathway in peripheral blood mononuclear cells in patients with active celiac disease. Dig Dis Sci. 2009; 54:1270–1275.
   Google Scholar
• Granzotto M, Dal Bo S, Quaglia S, Tommasini A, Piscianz E, Valencic E, Ferrara F, Martelossi S, Ventura A, Not T. Regulatory T-cell function is impaired in celiac disease. Dig Dis Sci. 2008; 54 7: 1513–1519.
   Google Scholar
• Gerli R, Pitzalis C, Bistoni O, Falini B, Costantini V, Russano A, Lunardi C. CD30 T cells in rheumatoid synovitis: Mechanisms of recruitment and functional role. J Immunol. 2000; 164:4399–4407.
   Google Scholar
• Gianfrani C, Levings MK, Sartirana C, Mazzarella G, Barba G, Zanzi D, Camarca A, Iaquinto G, Giardullo N, Auricchio S, Troncone R, Roncarolo MG. Gliadin-specific type 1 regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J Immunol. 2006; 177:4178–4186.
   PubMed Web of Science ®Google Scholar
• Benahmed M, Meresse B, Arnulf B, Barbe U, Mention JJ, Verkarre V, Allez M, Cellier C, Hermine O, Cerf-Bensussan N. Inhibition of TGF-beta signaling by IL-15: A new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology. 2007; 132:994–1008.
   PubMed Web of Science ®Google Scholar